Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified Health Condition 2: J459- Other and unspecified asthma
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Cipla Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either gender who are 18 years and above and understand English language and willing to participate in this study will be included.Patients diagnosed with asthma and COPD by the treating physician and prescribed inhaler as part of treatment of COPD or Asthma
Exclusion criteria
Exclusion criteria: Individuals suffering from malignancies AML and systemic autoimmune disease autoimmune diseases like SLE and other immunosuppressive disorders Individuals with any serious co-morbidity and existing end organ damage dementia and psychotic illness. Vulnerable patients less than 18 years old pregnant women Patients who do not understand English
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To examine the adherence of the BA-pMDI device compared to other inhaler devices for treatment of asthmatic and COPD patientsTimepoint: 9 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Identification of factors affecting adherence to the BA-pMDI devices and comparison to the different inhaler devices.Timepoint: 9 months | — |
Countries
India
Contacts
Public ContactDr Snehal Kulkarni
Chest Research and Training Private Limited
Outcome results
None listed